StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care total assets

Total assets on the balance sheet at the end of each period.

Tandem Diabetes Care's total assets was $1.15B at Jun 30, 2026. For fiscal 2025 it was $881.11M, down 8.9% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $1.05B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$881.11M-8.9%
FY2024Dec 31, 2024$967.66M+1.6%
FY2023Dec 31, 2023$952.66M-9.5%
FY2022Dec 31, 2022$1.05B+16.3%
FY2021Dec 31, 2021$905.14M+26.3%
FY2020Dec 31, 2020$716.42M+119.7%
FY2019Dec 31, 2019$326.11M+58.1%
FY2018Dec 31, 2018$206.29M+116.4%
FY2017Dec 31, 2017$95.35M-15.2%
FY2016Dec 31, 2016$112.39M-9.9%
FY2015Dec 31, 2015$124.73M+17.2%
FY2014Dec 31, 2014$106.46M-34.4%
FY2013Dec 31, 2013$162.22M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.15B+31.8%
Q1 FY2026Mar 31, 2026$1.15B+25.1%
Q4 FY2025Dec 31, 2025$881.11M-8.9%
Q3 FY2025Sep 30, 2025$874.65M-8.7%
Q2 FY2025Jun 30, 2025$875.74M-6.6%
Q1 FY2025Mar 31, 2025$922.14M-2.0%
Q4 FY2024Dec 31, 2024$967.66M+1.6%
Q3 FY2024Sep 30, 2024$957.73M+1.9%
Q2 FY2024Jun 30, 2024$937.50M-1.0%
Q1 FY2024Mar 31, 2024$941.05M-1.4%
Q4 FY2023Dec 31, 2023$952.66M-9.5%
Q3 FY2023Sep 30, 2023$939.91M-10.3%
Q2 FY2023Jun 30, 2023$946.68M-8.7%
Q1 FY2023Mar 31, 2023$954.15M-6.0%
Q4 FY2022Dec 31, 2022$1.05B+16.3%
Q3 FY2022Sep 30, 2022$1.05B+23.2%
Q2 FY2022Jun 30, 2022$1.04B+30.3%
Q1 FY2022Mar 31, 2022$1.02B+34.6%
Q4 FY2021Dec 31, 2021$905.14M+26.3%
Q3 FY2021Sep 30, 2021$850.28M+26.3%
Q2 FY2021Jun 30, 2021$795.25M+29.0%
Q1 FY2021Mar 31, 2021$754.27M+119.7%
Q4 FY2020Dec 31, 2020$716.42M+119.7%
Q3 FY2020Sep 30, 2020$672.99M+130.0%
Q2 FY2020Jun 30, 2020$616.24M+141.6%
Q1 FY2020Mar 31, 2020$343.33M+59.9%
Q4 FY2019Dec 31, 2019$326.11M+58.1%
Q3 FY2019Sep 30, 2019$292.65M+61.1%
Q2 FY2019Jun 30, 2019$255.08M+61.4%
Q1 FY2019Mar 31, 2019$214.70M+48.4%
Q4 FY2018Dec 31, 2018$206.29M+116.4%
Q3 FY2018Sep 30, 2018$181.61M+106.4%
Q2 FY2018Jun 30, 2018$157.99M+60.3%
Q1 FY2018Mar 31, 2018$144.70M+28.4%
Q4 FY2017Dec 31, 2017$95.35M-15.2%
Q3 FY2017Sep 30, 2017$87.98M-2.6%
Q2 FY2017Jun 30, 2017$98.54M–
Q1 FY2017Mar 31, 2017$112.71M–
Q4 FY2016Dec 31, 2016$112.39M–
Q3 FY2016Sep 30, 2016$90.33M–

More Tandem Diabetes Care figures

See a number that looks wrong?